9 unknown, 7 active not recruiting, 7 recruiting, 1 completed. 8 Not applicable, 8 Phase 2, 3 Phase 1, 1 Phase 3.
Follow Biopsy, Large-Core Needle: new trials by email Literature Review of Biopsy, Large-Core Needle trials Research Report on Biopsy, Large-Core Needle
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer Multitarget Tyrosine Kinase Inhibitors, BRAF inhibitor dabrafenib and MEK inhibitor trametinib, RET Inhibitor - Thyroid Cancer, Thyroid Neoplasms | Recruiting | Fujian Medical University | 120 | 2025-12-23 | 2026-02-19 | |
| New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease Lymph Node or Core Needle Biopsy, Fine Needle Aspiration, Tiny Isothermal Nucleic acid Amplification System (TINY) - HIV, Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease | Not applicable | Recruiting | Indiana University | 500 | 2025-03-17 | 2026-08-28 |
| Study of Acquired Resistance to Alkylator Chemotherapy in Endocrine Neoplasms Core needle biopsy, Phlebotomy - Neuroendocrine (NE) Tumors, Endocrine Cancer | Recruiting | Uppsala University | 94 | 2025-03-01 | 2025-08-14 | |
| Cryobiopsy for Suspected Malignant Peripheral Lymphadenopathy Cryobiopsy, Core Needle Biopsy - Cryobiopsy of Peripheral Lymph Nodes | Not applicable | Unknown | San Antonio Uniformed Services Health Education Consortium | 490 | 2023-12-01 | 2023-11-07 |
| Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02) Core Needle Biopsy, Forceps Biopsy, Punch Biopsy - Immunotherapy, Cancer | Active not recruiting | Elephas | 416 | 2023-06-26 | 2026-06-29 | |
| Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma Biospecimen Collection, Computed Tomography, Core Biopsy - Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 56 | 2023-03-07 | 2026-05-22 |
| Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors BET Bromodomain Inhibitor ZEN-3694, Computed Tomography, Core Biopsy - Advanced Malignant Solid Neoplasm, Locally Advanced Pancreatic Carcinoma | Phase 1 / Phase 2 | Recruiting | National Cancer Institute (NCI) | 49 | 2022-11-16 | 2026-07-15 |
| Image-based AI Predictive Biomarkers for Precision Neoadjuvant Triple-negative Breast Cancer Treatment Core needle biopsy - Triple Negative Breast Cancer, Triple Negative Breast Neoplasms | Terminated | Ourotech, Inc. | 34 | 2022-06-06 | 2025-07-30 | |
| Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients Needle Core Biopsies - Breast Cancer, Breast Neoplasms | Recruiting | Sunnybrook Health Sciences Centre | 25 | 2021-07-21 | 2025-01-20 | |
| Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer Camrelizumab and Apatinib, surgery, core needle biopsy - Thyroid Cancer | Phase 2 | Unknown | Fudan University | 31 | 2020-12-01 | 2020-11-03 |
| NeoVax With Nivolumab in Patients With Ovarian Cancer Nivolumab, NeoVax, Core Needle Biopsy - Ovarian Cancer | Phase 1 | Active not recruiting | Dana-Farber Cancer Institute | 22 | 2020-11-20 | 2026-10-08 |
| Comparison Study of Different Tumor Biopsy Method for Sentinel Lymph Node Biopsy in Breast Cancer Vacuum-Assisted Biopsy, Core Needle Biopsy, Intraoperative Excisional Biopsy - Breast Cancer, Sentinel Lymph Node | Not applicable | Unknown | Shandong Cancer Hospital and Institute | 600 | 2020-11-01 | 2020-10-27 |
| Comparison Trial of Open-tip Pulsed Needle Biopsy and Conventional Core Biopsy in Axillary Lymph Nodes Open-tip pulsed needle biopsy (NeoNavia Biopsy System), Core needle biopsy (CNB) - Breast Cancer | Not applicable | Unknown | NeoDynamics AB | 479 | 2020-07-13 | 2023-06-01 |
| Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast Afimoxifene, Core Biopsy, Questionnaire Administration - Cancer Survivor, Ductal Breast Carcinoma In Situ | Phase 2 | Active not recruiting | Northwestern University | 156 | 2020-02-17 | 2025-10-09 |
| Cryoablation for the Treatment of Metastatic Cancer Core Biopsy, Cryosurgery, Immunotherapeutic Agent - Metastatic Malignant Neoplasm | Not applicable | Active not recruiting | M.D. Anderson Cancer Center | 15 | 2019-12-23 | 2026-08-06 |
| RANKL Inhibition and Mammographic Breast Density Denosumab, Placebo, Calcium - Dense Breasts | Phase 2 | Active not recruiting | Washington University School of Medicine | 210 | 2019-08-27 | 2026-10-09 |
| A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma Computed Tomography, Core Biopsy, Magnetic Resonance Imaging - Stage III Uterine Corpus Leiomyosarcoma AJCC v8, Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 23 | 2019-08-19 | 2026-07-31 |
| Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer Anlotinib, surgery, core needle biopsy - Thyroid Cancer | Phase 2 | Unknown | Fudan University | 13 | 2019-06-01 | 2021-04-01 |
| Biomarker Study of Pancreatic Neuroendocrine Tumours 18F-FDG-PET, 68Ga-DOTATOC-PET, Computed tomography - Pancreatic Neuroendocrine Tumor | Unknown | Uppsala University | 40 | 2019-01-30 | 2022-05-18 | |
| RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy Core needle biopsy - Breast Neoplasm Female | Not applicable | Active not recruiting | Rna Diagnostics Inc. | 801 | 2018-04-26 | 2026-05-28 |
Showing 20 of 26. Sign in to see all of them.
Breast Neoplasms (8) · Thyroid Neoplasms (3) · Hodgkin Disease (2) · Lymphoma (2) · Neoplasm Metastasis (2) · Neoplasms (2) · Triple Negative Breast Neoplasms (2) · Adenoma, Islet Cell (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Intraductal, Noninfiltrating (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Colorectal Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endometrial Neoplasms (1)
Shandong Cancer Hospital and Institute (3) · Uppsala University (3) · Fudan University (2) · National Cancer Institute (NCI) (2) · Dana-Farber Cancer Institute (1) · Elephas (1) · Fujian Medical University (1) · Indiana University (1) · Jewish General Hospital (1) · Jonsson Comprehensive Cancer Center (1) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · NeoDynamics AB (1) · Northwestern University (1) · Ourotech, Inc. (1)
United States (13) · China (6) · Canada (3) · Sweden (3) · United Kingdom (2) · France (1) · Germany (1) · Italy (1) · Malawi (1) · Poland (1) · Spain (1)
Adetunji T Toriola, M.D., Ph.D. (1) · Alda L Tam (1) · Barbro Eriksson, MD PhD (1) · Daniele Generali, MD (1) · Eva Ciruelos, MD (1) · Foluso Ademuyiwa, MD (1) · Fred Hausheer, MD, FACP (1) · Joakim Crona, MD PhD (1) · Joke Tio, MD (1) · Katarzyna J Jerzak, MD MSc FRCPC (1) · Mark Basik, MD (1) · Maureen Trudeau, MD (1) · Mia C Weiss (1) · Michael Painschab, MD (1) · Panagiotis Konstantinopoulos, MD (1)
PMID 32693797, PMID 32996592, PMID 33927108, PMID 34610756, PMID 37467452, PMID 38113421, PMID 38969866, PMID 39352751, PMID 39863139, PMID 40791544, PMID 41484629, PMID 42875558
P30CA060553 (1), P50CA097274 (1), P50CA240243 (1), R37CA235602 (1), UM1CA186686 (1), UM1CA186689 (1)